Category Archives: Medication error

Amphotericin: Confusion between non-lipid and lipid formulations

Posted on September 3, 2007 by admin

The National Patient Safety Agency (NPSA) has issued a rapid response report Risk of confusion between non-lipid and lipid formulations of injectable amphotericin. The National Patient Safety Agency (NPSA) is alerting all healthcare staff involved in the use of intravenous … Continue reading →

Posted in Medication error | Comments Off

Nine steps to Safety

Posted on May 9, 2007 by admin

The WHO have launched their nine steps to safety to combat healthcare-related injuries. Look-alike, sound-alike medication names; patient identification; communication during patient hand-overs; performance of correct procedure at correct body site; control of concentrated electrolyte solutions; assuring medication accuracy at … Continue reading →

Posted in Medication error, Patient Safety, WHO | Comments Off

Reminyl/Amaryl confusion

Posted on October 28, 2004 by admin

Janssen and Johnson & Johnson have become aware of several reports of medications errors arising out of confusion between Reminyl (galantamine) and Amaryl (glimepiride). Several of these events have led to hypoglycaemia with one death. Dear Healthcare Professional letter

Posted in Medication error | Comments Off